These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 24610410

  • 1. Arsenic disulfide induced apoptosis and concurrently promoted erythroid differentiation in cytokine-dependent myelodysplastic syndrome-progressed leukemia cell line F-36p with complex karyotype including monosomy 7.
    Hu XM, Tanaka S, Onda K, Yuan B, Toyoda H, Ma R, Liu F, Hirano T.
    Chin J Integr Med; 2014 May; 20(5):387-93. PubMed ID: 24610410
    [Abstract] [Full Text] [Related]

  • 2. Arsenic disulfide-triggered apoptosis and erythroid differentiation in myelodysplastic syndrome and acute myeloid leukemia cell lines.
    Hu XM, Yuan B, Tanaka S, Song MM, Onda K, Tohyama K, Zhou AX, Toyoda H, Hirano T.
    Hematology; 2014 Sep; 19(6):352-60. PubMed ID: 24192507
    [Abstract] [Full Text] [Related]

  • 3. Effects of arsenic disulfide on apoptosis, histone acetylation, toll like receptor 2 activation, and erythropoiesis in bone marrow mononuclear cells of myelodysplastic syndromes patients in vitro.
    Xu M, Ren JY, Guo YC, Xu BX, Zeng Q, Hu Q, Zhou YM, Lu JH.
    Leuk Res; 2017 Nov; 62():4-11. PubMed ID: 28963909
    [Abstract] [Full Text] [Related]

  • 4. Arsenic Disulfide Promoted Hypomethylation by Increasing DNA Methyltransferases Expression in Myelodysplastic Syndrome.
    Zhou QB, Liu ZT, Wang HZ, Guo XQ, Xu YG, Hu XM.
    Drug Des Devel Ther; 2020 Nov; 14():1641-1650. PubMed ID: 32431489
    [Abstract] [Full Text] [Related]

  • 5. [Apoptosis of in vitro cultured BMMNC from MDS patients induced by arsenic sulfide].
    Yuan HJ, Xu RR, Ding RS, Jiang SH, Lu W.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Apr; 14(2):276-80. PubMed ID: 16638196
    [Abstract] [Full Text] [Related]

  • 6. Oral Arsenic-Containing Qinghuang Powder: A Potential Drug for Myelodysplastic Syndromes.
    Ming J, Liu WY, Xiao HY, Xu YG, Ma R, Hu XM.
    Chin J Integr Med; 2022 Aug; 28(8):762-768. PubMed ID: 32146594
    [Abstract] [Full Text] [Related]

  • 7. Anti-liver cancer effect and the mechanism of arsenic sulfide in vitro and in vivo.
    Wang S, Zhang C, Li Y, Li P, Zhang D, Li C.
    Cancer Chemother Pharmacol; 2019 Mar; 83(3):519-530. PubMed ID: 30542770
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effects of arsenic disulfide on proliferation, cytokine production, and frequencies of CD4(+), CD8(+), and regulatory T cells in mitogen-activated human peripheral blood mononuclear cells.
    Song MM, Fang S, Tanaka S, Sugiyama K, Kiyomi A, Kato R, Onda K, Yuan B, Takagi N, Hu X, Hirano T.
    Int Immunopharmacol; 2015 Dec; 29(2):832-838. PubMed ID: 26359544
    [Abstract] [Full Text] [Related]

  • 10. Establishment and erythroid differentiation of a cytokine-dependent human leukemic cell line F-36: a parental line requiring granulocyte-macrophage colony-stimulating factor or interleukin-3, and a subline requiring erythropoietin.
    Chiba S, Takaku F, Tange T, Shibuya K, Misawa C, Sasaki K, Miyagawa K, Yazaki Y, Hirai H.
    Blood; 1991 Nov 01; 78(9):2261-8. PubMed ID: 1834251
    [Abstract] [Full Text] [Related]

  • 11. Arsenic sulfide induces apoptosis and autophagy through the activation of ROS/JNK and suppression of Akt/mTOR signaling pathways in osteosarcoma.
    Wang G, Zhang T, Sun W, Wang H, Yin F, Wang Z, Zuo D, Sun M, Zhou Z, Lin B, Xu J, Hua Y, Li H, Cai Z.
    Free Radic Biol Med; 2017 May 01; 106():24-37. PubMed ID: 28188923
    [Abstract] [Full Text] [Related]

  • 12. Functional disturbance of marrow stromal microenvironment in the myelodysplastic syndromes.
    Tauro S, Hepburn MD, Peddie CM, Bowen DT, Pippard MJ.
    Leukemia; 2002 May 01; 16(5):785-90. PubMed ID: 11986938
    [Abstract] [Full Text] [Related]

  • 13. Apoptotic effect of As2S2 on K562 cells and its mechanism.
    Li JE, Wu WL, Wang ZY, Sun GL.
    Acta Pharmacol Sin; 2002 Nov 01; 23(11):991-6. PubMed ID: 12421474
    [Abstract] [Full Text] [Related]

  • 14. [Biologic changes in MDS-L cell line induced by As2O3 and/or TRAIL].
    Li X, Pu Q, Shen WM, Tohyama K, Deeg HJ.
    Zhonghua Xue Ye Xue Za Zhi; 2004 Oct 01; 25(10):605-9. PubMed ID: 15634594
    [Abstract] [Full Text] [Related]

  • 15. Antitumor effects of arsenic disulfide on the viability, migratory ability, apoptosis and autophagy of breast cancer cells.
    Zhao Y, Onda K, Sugiyama K, Yuan B, Tanaka S, Takagi N, Hirano T.
    Oncol Rep; 2019 Jan 01; 41(1):27-42. PubMed ID: 30320388
    [Abstract] [Full Text] [Related]

  • 16. Discordant detection of monosomy 7 by GTG-banding and FISH in a patient with Shwachman-Diamond syndrome without evidence of myelodysplastic syndrome or acute myelogenous leukemia.
    Sokolic RA, Ferguson W, Mark HF.
    Cancer Genet Cytogenet; 1999 Dec 01; 115(2):106-13. PubMed ID: 10598142
    [Abstract] [Full Text] [Related]

  • 17. Arsenic Disulfide Combined with L-Buthionine-(S, R)-Sulfoximine Induces Synergistic Antitumor Effects in Two-Dimensional and Three-Dimensional Models of MCF-7 Breast Carcinoma Cells.
    Zhao Y, Tanaka S, Yuan B, Sugiyama K, Onda K, Kiyomi A, Takagi N, Sugiura M, Hirano T.
    Am J Chin Med; 2019 Dec 01; 47(5):1149-1170. PubMed ID: 31311297
    [Abstract] [Full Text] [Related]

  • 18. Artesunate induces apoptosis through caspase-dependent and -independent mitochondrial pathways in human myelodysplastic syndrome SKM-1 cells.
    Wang Y, Yang J, Chen L, Wang J, Wang Y, Luo J, Pan L, Zhang X.
    Chem Biol Interact; 2014 Aug 05; 219():28-36. PubMed ID: 24704559
    [Abstract] [Full Text] [Related]

  • 19. Engraftment of human myelodysplastic syndrome derived cell line in transgenic severe combined immunodeficient (TG-SCID) mice expressing human GM-CSF and IL-3.
    Kim DK, Kojima M, Fukushima T, Miyasaka M, Nakauchi H.
    Eur J Haematol; 1998 Aug 05; 61(2):93-9. PubMed ID: 9714520
    [Abstract] [Full Text] [Related]

  • 20. Relation of Blood Arsenic Concentration with Effect and Safety of Arsenic-Containing Qinghuang Powder () in Patients with Myelodysplastic Syndrome.
    Deng ZY, Zhu SR, Wang MJ, Fang S, Zhao P, Zhu QZ, Wang HZ, Guo XQ, Xu YG, Yi BW, Shang XH, Ma R, Hu XM.
    Chin J Integr Med; 2019 Jul 05; 25(7):497-501. PubMed ID: 31278627
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.